相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Aβ impairs nicotinic regulation of inhibitory synaptic transmission and interneuron excitability in prefrontal cortex
Guo-Jun Chen et al.
MOLECULAR NEURODEGENERATION (2013)
Uncoupling of M1 muscarinic receptor/G-protein interaction by amyloid β1-42
Helena Janickova et al.
NEUROPHARMACOLOGY (2013)
The muscarinic M1 receptor positive allosteric modulator PQCA improves cognitive measures in rat, cynomolgus macaque, and rhesus macaque
Jason M. Uslaner et al.
PSYCHOPHARMACOLOGY (2013)
Cholinergic modulation of amyloid precursor protein processing with emphasis on M1 muscarinic receptor: perspectives and challenges in treatment of Alzheimer's disease
Abraham Fisher
JOURNAL OF NEUROCHEMISTRY (2012)
BACE1 is at the crossroad of a toxic vicious cycle involving cellular stress and β-amyloid production in Alzheimer's disease
Linda Chami et al.
MOLECULAR NEURODEGENERATION (2012)
M1 muscarinic acetylcholine receptor interacts with BACE1 and regulates its proteosomal degradation
Shangtong Jiang et al.
NEUROSCIENCE LETTERS (2012)
Pre- and post-synaptic cortical cholinergic deficits are proportional to amyloid plaque presence and density at preclinical stages of Alzheimer's disease
Pamela E. Potter et al.
ACTA NEUROPATHOLOGICA (2011)
ERK1-independent α-secretase cut of β-amyloid precursor protein via M1 muscarinic receptors and PKCα/ε
Moustapha Cisse et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2011)
Alzheimer's disease: synapses gone cold
Robert M. Koffie et al.
MOLECULAR NEURODEGENERATION (2011)
Biology and pathophysiology of the amyloid precursor protein
Hui Zheng et al.
MOLECULAR NEURODEGENERATION (2011)
APP processing in Alzheimer's disease
Yun-Wu Zhang et al.
MOLECULAR BRAIN (2011)
Discovery and Characterization of Novel Subtype-Selective Allosteric Agonists for the Investigation of M1 Receptor Function in the Central Nervous System
Evan P. Lebois et al.
ACS CHEMICAL NEUROSCIENCE (2010)
Deletion of M1 Muscarinic Acetylcholine Receptors Increases Amyloid Pathology In Vitro and In Vivo
Albert A. Davis et al.
JOURNAL OF NEUROSCIENCE (2010)
Allosteric activators of muscarinic receptors as novel approaches for treatment of CNS disorders
Gregory J. Digby et al.
MOLECULAR BIOSYSTEMS (2010)
AC-260584, an orally bioavailable M1 muscarinic receptor allosteric agonist, improves cognitive performance in an animal model
Stefania Risso Bradley et al.
NEUROPHARMACOLOGY (2010)
A novel derivative of xanomeline improves fear cognition in aged mice
Wen Si et al.
NEUROSCIENCE LETTERS (2010)
M-1 muscarinic receptor for the development of auditory cortical function
Karalee K. Shideler et al.
MOLECULAR BRAIN (2010)
A Selective Allosteric Potentiator of the M1 Muscarinic Acetylcholine Receptor Increases Activity of Medial Prefrontal Cortical Neurons and Restores Impairments in Reversal Learning
Jana K. Shirey et al.
JOURNAL OF NEUROSCIENCE (2009)
The Activation of M1 Muscarinic Receptor Signaling Induces Neuronal Differentiation in Pyramidal Hippocampal Neurons
Kathryn L. VanDeMark et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Discovery and Characterization of Novel Allosteric Potentiators of M1 Muscarinic Receptors Reveals Multiple Modes of Activity
Joy E. Marlo et al.
MOLECULAR PHARMACOLOGY (2009)
Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders
P. Jeffrey Conn et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Selective activation of the M1 muscarinic acetylcholine receptor achieved by allosteric potentiation
Lei Ma et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Neuronal M3 muscarinic acetylcholine receptors are essential for somatotroph proliferation and normal somatic growth
Dinesh Gautam et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Disease-modifying therapies in Alzheimer's disease
Stephen Salloway et al.
ALZHEIMERS & DEMENTIA (2008)
Characterization of a CNS penetrant, selective M1 muscarinic receptor agonist, 77-LH-28-1
C. J. Langmead et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Cholinergic neuronal and axonal abnormalities are present early in aging and in Alzheimer disease
Changiz Geula et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2008)
Novel Selective Allosteric Activator of the M1 Muscarinic Acetylcholine Receptor Regulates Amyloid Processing and Produces Antipsychotic-Like Activity in Rats
Carrie K. Jones et al.
JOURNAL OF NEUROSCIENCE (2008)
Metabolic roles of the M-3 muscarinic acetylcholine receptor studied with M-3 receptor mutant mice: A review
Dinesh Gautam et al.
JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION (2008)
Interactions between the amyloid and cholinergic mechanisms in Alzheimer's disease
Magdolna Paskaski et al.
NEUROCHEMISTRY INTERNATIONAL (2008)
M1 muscarinic Agonists target major hallmarks of Alzheimer's disease the pivotal role of brain M1 receptors
Abraham Fisher
NEURODEGENERATIVE DISEASES (2008)
Cholinergic treatments with emphasis on M1 muscarinic agonists as potential disease-modifying agents for Alzheimer's disease
Abraham Fisher
NEUROTHERAPEUTICS (2008)
Muscarinic acetylcholine receptors as CNS drug targets
Christopher J. Langmead et al.
PHARMACOLOGY & THERAPEUTICS (2008)
Allosteric modulation of the muscarinic M4 receptor as an approach to treating schizophrenia
W. Y. Chan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
A novel derivative of xanomeline improved memory function in aged mice
Yi-Hui Cui et al.
Neuroscience Bulletin (2008)
Modulators in concert for cognition: Modulator interactions in the prefrontal cortex
Lisa A. Briand et al.
PROGRESS IN NEUROBIOLOGY (2007)
Pharmacological characterization of the muscarinic agonist (3R,4R)-3-(3-Hexylsulfanyl-pyrazin-2-yloxy)-1-azabicyclo[2.2.1] heptane (WAY-132983) in in vitro and in vivo models of chronic pain
Nicole R. Sullivan et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development
Juergen Wess et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Structural requirements of transmembrane domain 3 for activation by the M1 muscarinic receptor agonists AC-42, AC-260584, clozapine, and N-desmethylclozapine:: Evidence for three distinct modes of receptor activation
Tracy A. Spalding et al.
MOLECULAR PHARMACOLOGY (2006)
The role of acetylcholine in learning and memory
Michael E. Hasselmo
CURRENT OPINION IN NEUROBIOLOGY (2006)
Impaired coupling of muscarinic M1 receptors to G-proteins in the neocortex is associated with severity of dementia in Alzheimer's disease
Shirley W. Y. Tsang et al.
NEUROBIOLOGY OF AGING (2006)
Quantitative measurement of cerebral haemodynamics in early vascular dementia and Alzheimer's disease
Grant A. Bateman et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2006)
M1 receptors play a central role in modulating AD-like pathology in transgenic mice
A Caccamo et al.
NEURON (2006)
Modulation of synaptic plasticity by physiological activation of M1 muscarinic acetylcholine receptors in the mouse hippocampus
T Shinoe et al.
JOURNAL OF NEUROSCIENCE (2005)
Functional activity of the M2 and M4 receptor subtypes in the spinal cord studied with muscarinic acetylcholine receptor knockout mice
SR Chen et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Twenty years of the Alzheimer's disease amyloid hypothesis: A genetic perspective
RE Tanzi et al.
CELL (2005)
Muscarinic receptor agonists and antagonists in the treatment of Alzheimer's Disease
JW Clader et al.
CURRENT PHARMACEUTICAL DESIGN (2005)
Decrease in GTP-sensitive high affinity agonist binding of muscarinic acetylcholine receptors in autopsied brains of dementia with Lewy bodies and Alzheimer's disease
K Shiozaki et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2004)
Beta-secretase BACE1 is differentially controlled through muscarinic acetylcholine receptor signaling
T Züchner et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2004)
M1 muscarinic receptor activation protects neurons from β-amyloid toxicity.: A role for Wnt signaling pathway
GG Farías et al.
NEUROBIOLOGY OF DISEASE (2004)
Role for M5 muscarinic acetylcholine receptors in cocaine addiction
A Fink-Jensen et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2003)
Amyloid precursor protein processing in vivo -: Insights from a chemically-induced constitutive overactivation of protein kinase C in guinea pig brain
V Bigl et al.
CURRENT MEDICINAL CHEMISTRY (2003)
Use of M1-M5 muscarinic receptor knockout mice as novel tools to delineate the physiological roles of the muscarinic cholinergic system
FP Bymaster et al.
NEUROCHEMICAL RESEARCH (2003)
Muscarinic receptor activation protects cells from apoptotic effects of DNA damage, oxidative stress, and mitochondrial inhibition
P De Sarno et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Treatment with the selective muscarinic m1 agonist talsaclidine decreases cerebrospinal fluid levels of Aβ42 in patients with Alzheimer's disease
C Hock et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2003)
Heterogeneity of presynaptic muscarinic receptors mediating inhibition of sympathetic transmitter release:: a study with M2- and M4-receptor-deficient mice
AU Trendelenburg et al.
BRITISH JOURNAL OF PHARMACOLOGY (2003)
Structure and activation of muscarinic acetylcholine receptors
EC Hulme et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2003)
Loss of muscarinic M4 receptors in hippocampus of Alzheimer patients
E Mulugeta et al.
BRAIN RESEARCH (2003)
Selective cognitive dysfunction in acetylcholine M-1 muscarinic receptor mutant mice
SG Anagnostaras et al.
NATURE NEUROSCIENCE (2003)
Regional cerebral blood flow patterns and response to donepezil treatment in patients with Alzheimer's disease
H Hanyu et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2003)
Synthesis and pharmacology of benzoxazines as highly selective antagonists at M4 muscarinic receptors
TM Böhme et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Hyperactivity, elevated dopaminergic transmission, and response to amphetamine in M1 muscarinic acetylcholine receptor-deficient mice
DJ Gerber et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Therapeutic, opportunities from muscarinic receptor research
RM Eglen et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2001)
Reduction of cerebrospinal fluid amyloid β after systemic administration of M1 muscarinic agonists
TG Beach et al.
BRAIN RESEARCH (2001)
Therapeutic opportunities for muscarinic receptors in the central nervous system
CC Felder et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
Therapeutic strategies in Alzheimer's disease: M1 muscarinic agonists
A Fisher
JAPANESE JOURNAL OF PHARMACOLOGY (2000)
Tau protein isoforms, phosphorylation and role in neurodegenerative disorders
L Buée et al.
BRAIN RESEARCH REVIEWS (2000)
On neurodegenerative diseases, models, and treatment strategies: Lessons learned and lessons forgotten a generation following the cholinergic hypothesis
RT Bartus
EXPERIMENTAL NEUROLOGY (2000)
The muscarinic M5 receptor:: a silent or emerging subtype?
RM Eglen et al.
BRITISH JOURNAL OF PHARMACOLOGY (2000)
Muscarinic agonists reduce tau phosphorylation in non-neuronal cells via GSK-3 beta inhibition and in neurons
OV Forlenza et al.
JOURNAL OF NEURAL TRANSMISSION (2000)
M1 muscarinic receptors block caspase activation by phosphoinositide 3-kinase- and MAPK/ERK-independent pathways
C Leloup et al.
CELL DEATH AND DIFFERENTIATION (2000)
分享论文
